MEDIGENE
Live / Registered — Cancelled — Section 71 (as of 26 Feb 2021)
What this means for you
Registered since 17 Mar 2009. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79043515
- Registration number
- 3591359
- Mark type
- Stylized text
- Filed
- 27 Apr 2007
- Published for opposition
- 30 Dec 2008
- Registered
- 17 Mar 2009
- Attorney of record
- Adrienne L. White
Goods and services
- Class 005 — Pharmaceuticals: Medicines for humans and animals, except venous-therapeutics, namely, medicines for treating [ cardiovascular and vascular diseases, ] dermatological disorders and diseases, [ precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases, vaccines for treating cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; serums, namely, immune serums for passive vaccination for treating infectious diseases, diagnostic test kits comprising antibodies, antibody fragments, serums, soluble monoclonal T-cell receptors, peptides, peptide-analogues, enzymes, liposomes, dyes, radioactively labeled substances, for the purpose of testing, diagnosing and monitoring cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; proteins, proteinconjugates, peptides, enzymes and enzyme-preparations, antibodies, T-cell-proteins, attenuated viruses, virus-like particles, liposomes, ] herbal extracts, components of low molecular weight, all for use as medicines [, vaccines and parts of medical diagnostic test kits for treating, testing, diagnosing and monitoring all diseases mentioned above ]
Owner
- MediGene AG, DE
- MediGene AG, DE
- MediGene AG, DE
Prior registrations
Prosecution history
- 09 Jan 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 01 Dec 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 01 Dec 2021 — INVALIDATION PROCESSED
- 26 Oct 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Feb 2021 — CANCELLED SECTION 71
- 23 Aug 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 Mar 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 11 May 2017 — INTERNATIONAL REGISTRATION RENEWED
- 23 Mar 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 23 Mar 2015 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 23 Mar 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Mar 2015 — TEAS SECTION 71 & 15 RECEIVED
- 12 Jan 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Nov 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jul 2009 — FINAL DISPOSITION NOTICE SENT TO IB